Sinsin Pharmaceutical Co. Ltd (002800) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.066x

Based on the latest financial reports, Sinsin Pharmaceutical Co. Ltd (002800) has a cash flow conversion efficiency ratio of 0.066x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩4.70 Billion ≈ $3.18 Million USD) by net assets (₩71.01 Billion ≈ $48.12 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Sinsin Pharmaceutical Co. Ltd (002800) market capitalisation for the company's overall valuation and market capitalisation.

Sinsin Pharmaceutical Co. Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Sinsin Pharmaceutical Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Sinsin Pharmaceutical Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sinsin Pharmaceutical Co. Ltd ranked by their cash flow conversion efficiency. Explore 002800 cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Kestrel Group, Ltd. NASDAQ:KG	-0.330x
ENERGY&MACHINERY KOREA Co.Ltd KQ:095190	0.194x
Glaston Oyj Abp HE:GLA1V	0.006x
Grazziotin S.A SA:CGRA3	0.028x
Siam Steel Service Center Public Company Limited BK:SSSC	0.050x
Ekarat Engineering Public Company Limited BK:AKR	0.103x
Strongpoint ASA OL:STRO	0.061x
InkTec Co. Ltd KQ:049550	0.033x

Annual Cash Flow Conversion Efficiency for Sinsin Pharmaceutical Co. Ltd (2016–2024)

The table below shows the annual cash flow conversion efficiency of Sinsin Pharmaceutical Co. Ltd from 2016 to 2024. View Sinsin Pharmaceutical Co. Ltd share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩65.87 Billion ≈ $44.64 Million	₩5.94 Billion ≈ $4.03 Million	0.090x	+42.55%
2023-12-31	₩62.09 Billion ≈ $42.08 Million	₩3.93 Billion ≈ $2.66 Million	0.063x	-30.80%
2022-12-31	₩59.70 Billion ≈ $40.46 Million	₩5.46 Billion ≈ $3.70 Million	0.091x	+21570.98%
2021-12-31	₩54.93 Billion ≈ $37.22 Million	₩23.18 Million ≈ $15.71K	0.000x	-98.73%
2020-12-31	₩56.20 Billion ≈ $38.08 Million	₩1.87 Billion ≈ $1.26 Million	0.033x	+141.52%
2019-12-31	₩56.36 Billion ≈ $38.20 Million	₩-4.51 Billion ≈ $-3.05 Million	-0.080x	-663.11%
2018-12-31	₩54.54 Billion ≈ $36.96 Million	₩774.24 Million ≈ $524.69K	0.014x	-83.80%
2017-12-31	₩52.12 Billion ≈ $35.32 Million	₩4.57 Billion ≈ $3.10 Million	0.088x	+8.00%
2016-12-31	₩34.43 Billion ≈ $23.33 Million	₩2.79 Billion ≈ $1.89 Million	0.081x	--

About Sinsin Pharmaceutical Co. Ltd

KQ:002800 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$45.90 Million

₩67.74 Billion KRW

Market Cap Rank

#22294 Global

#1411 in Korea

Share Price

₩4465.00

Change (1 day)

+0.00%

52-Week Range

₩4015.00 - ₩6630.00

All Time High

₩13396.03